Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-α in human prostate cancer cells

British Journal of Cancer

Volumn 80, Issue 5-6, 1999, Pages 657-669

  Seth, D ^a   Shaw, K ^a   Jazayeri, J ^a   Leedman, P J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Autocrine loop; EGF receptor; mRNA stability; Prostate cancer; Protein stability

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032944473     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690407     Document Type: Article

References (56)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K (eds) (1994) Identification of newly transcribed RNA. In: Current Protocols in Molecular Biology. Wiley: Toronto
2. Beguinot L, Lyall RM, Willingham MC and Pastan I (1984) Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalisation and subsequent degradation in lysomes. Proc Natl Acad Sci USA 81: 2384-2388
3. Beguinot L, Hanover JA, Ito S, Richert ND, Willingham MC and Pastan I (1985) Phorbal esters induce transient internalisation without degradation of unoccupied epidermal growth factor receptors. Proc Natl Acad Sci USA 82: 2774-2778
4. Bilous M, Milliken J and Mathijs JM (1992) Immunocytochemistry and in situ hybridization of epidermal growth factor receptor and relation to prognostic factors in breast cancer. Eur J Cancer 28: 1033-1037
5. Brass AL, Bamard J, Patai BL, Salvi D and Rukstalis DB (1995) Androgen up-regulates growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Cancer Res 55: 3197-3203
6. Burden S and Yarden Y (1997) Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 18: 847-855
7. Byrne RL, Leung H and Neal DE (1996) Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol 77: 627-633
8. Carruba G, Leake RE, Rinaldi F, Chalmers D, Comito L, Sorci C, Pavone-Macaluso M and Castagnetta LAM (1994) Steroid-growth factor interaction in human prostate cancer. Part I: Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59: 412-420
9. Ching KZ, Ramsey E, Pettigrew N, D'Cuhna R, Jason M and Dodd JG (1993) Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126: 151-158
10. Clark AJ, Ishii S, Richert N, Merlino GT and Pastan I (1985) Epidermal growth factor stimulates the expression of its own receptor. Proc Natl Acad Sci USA 82: 8374-8378
11. Connolly JM and Rose DP (1990) Production of epidermal growth factor and transforming growth factor-α by androgen-responsive LNCaP human prostate cancer cell line. Prostate 16: 209-218
12. Connolly JM and Rose DP (1991) Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19: 173-180
13. Davies P and Eaton C (1989) Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate 14: 123-132
14. Decker CJ and Parker R (1994) Mechanisms of mRNA degradation in eukaryotes. Trends Biochem Sci 19: 336-340
15. Earp HS, Austin KS, Blaisdall J, Rubin RA, Nelson KG, Lee LW and Grisham JW (1986) Epidermal growth factor stimulates EGF receptor synthesis. J Biol Chem 261: 4777-4780
16. Ebner R and Derynck R (1991) Epidermal growth factor and transforming growth factor alpha; differential intracellular routing and processing of ligand-receptor complexes. Cell Regul 2: 599-612
17. Ennis BW, Valverius EM, Bates SE, Lippman ME, Bellot F, Kris R, Schlessinger J, Masui H, Goldenberg A, Mendelsohn J and Dickson RB (1989) Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA468 human breast cancer cells. Mol Endocrinol 3: 1830-1838
18. Fernandez-Pol JA, Hamilton PD and Klos DJ (1989) Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor β1, and triiodothyronine in MDA468 cells. J Biol Chem 264: 4151-4156
19. French AR, Tadaki DK, Niyogi SK and Lauffenburger DA (1995) Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem 270: 4334-4340
20. Glynne Jones E, Goddard L and Harper ME (1996) Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue. Hum Pathol 27: 688-694
21. Greenberg ME and Belasco JG (1993) Control of degradation of labile protooncogene and lymphokine mRNAs. In: Control of mRNA Stability, Belasco JG and Brawerman G (eds), pp. 199-218. Academic Press: London
22. Gullick WJ (1991) Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47: 87-96
23. Hanover JA, Beguinot L, Willingham MC and Pastan IH (1985) Transit of receptors for epidermal growth factor and transferrin through clathrincoated pits. Analysis of the kinetics of receptor entry. J Biol Chem 260: 15938-15945
24. Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J and Lee C (1991) Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor α. Cancer Res 51: 2780-2785
25. Jarrard DF, Blitz BF, Smith RC, Patai BL and Rukstalis DB (1994) Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion. Prostate 24: 46-53
26. Jinno Y, Merlino GT and Pastan I (1988) A novel effect of EGF on mRNA stability. Nucl Acid Res 16: 4957-4966
27. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH and Mendelsohn J (1983) Growth stimulation of A431 cells by epidermal growth factor: identification of high affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 80: 1337-1341
28. Kesavan P, Mukhopadhyay S, Murphy S, Rengaraju M, Lazar MA and Das M (1991) Thyroid hormone decreases the expression of epidermal growth factor receptor. J Biol Chem 266: 10282-10286
29. Kudlow JE, Cheung C-YM and Bjorge JD (1986) Epidermal growth factor stimulates its own receptor in a human breast cancer cell line. J Biol Chem 261: 4134-4138
30. Kurten RC, Cadena DL and Gill GN (1996) Enhanced degradation of EGF receptors by a sorting nexin, SNX1. Science 272: 1008-1010
31. Lifshitz A, Lazar CS, Buss JE and Gill GN (1983) Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor. J Cell Physiol 115: 235-242
32. Lippman ME (1993) The development of biological therapies for breast cancer. Science 259: 631-632
33. Liu X-H, Wiley HS and Mickle AW (1993) Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α and epidermal growth factor/TGF-α receptor. J Clin Endocrinol Metab 77: 1472-1478
34. Maddy SQ, Chisholm GD, Busuttil A and Habib FK (1989) Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumor. Br J Cancer 60: 41-44
35. Mendelsohn J (1992) Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. J Natl Cancer Inst Monogr 13: 125-131
36. Modjtahedi H and Dean C (1994) The receptor for EGF and its ligands: expression, prognostic value and target for therapy in cancer. Int J Oncol 4: 277-296
37. Morris GL and Dodd JG (1990) Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143: 1272-1274
38. Nomura AMY and Kolonel N (1991) Prostate cancer: a current perspective. Am Epidemiol 18: 200-226
39. Peltz SW and Jacobson A (1992) Regulation of mRNA turnover in eukaryotic cells. Curr Opin Cell Biol 4: 979-983
40. Prewett M, Rockwell P, Rockwell RF, Giorgio NA, Mendelsohn J, Scher HI and Goldstein NI (1997) The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma. J Immunother 19: 419-427
41. Sachs AB (1993) Messenger RNA degradation in eukaryotes. Cell 74: 413-421
42. Schuurmans ALG, Bolt J and Mulder E (1988) Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell line LNCaP. Prostate 12: 55-63
43. Schuurmans ALG, Bolt J, Veldscholle J and Mulder E (1991) Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Molec Biol 40: 193-197
44. Steiner MS (1993) Role of peptide growth factors in the prostate: a review. Urology 42: 99-110
45. Steiner MS and Barrack ER (1992) Transforming growth factor β-1 overproduction in prostate cancer: effects of growth in vivo and in vitro. Mol Endocrinol 6: 15-25
46. Tilbrook PA, Bittorf T, Busfield SJ, Chappell D and Klinken SP (1996) Disrupted signalling in a mutant J2E cell line that shows enhanced viability, but does not proliferate or differentiate, with erythropoietin. J Biol Chem 271: 3453-3459
47. Todaro GJ, Fryling C and DeLarco JE (1979) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258-5262
48. Traish AM, Wotiz, HH (1987) Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology 121: 1461-1467
49. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE and Macoska JA (1994) Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate 25: 199-205
50. Tzahar E, Pinkas-Kramarski R, Moyer J, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC and Yarden Y (1997) Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J 16: 4938-4950
51. Vieira AV, Lamaze C and Schmid SL (1996) Control of EGF receptor signalling by clathrin-mediated endocytosis. Science 274: 2086-2089
52. Waterman H, Sabanai I, Geiger B and Yarden Y (1998) Alternative intracellular routing of erbB receptors may determine signaling potency. J Biol Chem 273: 13819-13827
53. Wilding G, Valverius E, Knabbe C and Gelmann EP (1989) Role of transforming growth factor-α in human prostate cancer cell growth. Prostate 15: 1-12
54. Wiley HS, Herbst JJ, Walsh BJ, Lauffenburger DA, Rosenfeld MG, Gill GN (1991) The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem 266: 11083-11094
55. Xie H, Turner T, Wang M-H, Singh RK, Siegal GP and Wells A (1995) In vitro invasiveness of DU145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis 13: 407-419
56. Zhau HY, Chang S-M, Chen B-Q, Wang Y, Zhang H, Kao C, Sang QA, Pathak SJ and Chung LW (1996) Androgen-repressed phenotype in prostate cancer. Proc Natl Acad Sci USA 93: 15152-15157